Work

A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Scandinavian Journal of Infectious Diseases

DOI: 10.1080/23744235.2024.2410466

Authors: Sai Krishna Susarla, Manish Narang, Prashant Namdev Khandgave, Lipilekha Patnaik, Vasudev Rajapantula, Satish M, Rajashakar BC, Devi Prasad Sahoo, Anand Kumar Kanakasapapathy

Institutions: Indian Immunologicals (India), Guru Teg Bahadur Hospital, Siksha O Anusandhan University, Institute of Medical Sciences and Sum Hospital, King George Hospital, King George Hospital

Language: English

Topic: Diphtheria, Corynebacterium, and Tetanus

Subfield: Endocrinology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403214499

FWCI:

Cites: 10

Cited by:

Related to: 10